Related Experiment Videos
Respiratory syncytial virus immune globulin and conflict of interest
The New England Journal of Medicine
|December 29, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2003
Respiratory syncytial virus prophylaxis--the story so far.
Respiratory medicine·2002
Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial. Northern Hemisphere Expanded Access Study Group.
The Pediatric infectious disease journal·2001
Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia.
The Journal of infectious diseases·1998
Clinical Uses of Common Genetic Variants Associated with Common Diseases.
The New England journal of medicine·2026
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome.
The New England journal of medicine·2026
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma.
The New England journal of medicine·2026
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis.
The New England journal of medicine·2026
Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.
Pharmaceuticals (Basel, Switzerland)·2026